380 related articles for article (PubMed ID: 29675145)
21. Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship.
Leamon CP; Vlahov IR; Reddy JA; Vetzel M; Santhapuram HK; You F; Bloomfield A; Dorton R; Nelson M; Kleindl P; Vaughn JF; Westrick E
Bioconjug Chem; 2014 Mar; 25(3):560-8. PubMed ID: 24564229
[TBL] [Abstract][Full Text] [Related]
22. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
23. Assessment of folate receptor-β expression in human neoplastic tissues.
Shen J; Putt KS; Visscher DW; Murphy L; Cohen C; Singhal S; Sandusky G; Feng Y; Dimitrov DS; Low PS
Oncotarget; 2015 Jun; 6(16):14700-9. PubMed ID: 25909292
[TBL] [Abstract][Full Text] [Related]
24. Folate receptor expression on murine and human adipose tissue macrophages.
Hansen MJ; Achini Bandara N; Low PS
Inflamm Res; 2015 Sep; 64(9):697-706. PubMed ID: 26149693
[TBL] [Abstract][Full Text] [Related]
25. Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry.
Carron PM; Crowley A; O'Shea D; McCann M; Howe O; Hunt M; Devereux M
Curr Med Chem; 2018; 25(23):2675-2708. PubMed ID: 29424300
[TBL] [Abstract][Full Text] [Related]
26. Targeting of herbal bioactives through folate receptors: a novel concept to enhance intracellular drug delivery in cancer therapy.
Gupta A; Kaur CD; Saraf S; Saraf S
J Recept Signal Transduct Res; 2017 Jun; 37(3):314-323. PubMed ID: 28095746
[TBL] [Abstract][Full Text] [Related]
27. Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys.
Yang JJ; Kularatne SA; Chen X; Low PS; Wang E
Mol Pharm; 2012 Feb; 9(2):310-7. PubMed ID: 22171616
[TBL] [Abstract][Full Text] [Related]
28. Imaging the folate receptor on cancer cells with 99mTc-etarfolatide: properties, clinical use, and future potential of folate receptor imaging.
Maurer AH; Elsinga P; Fanti S; Nguyen B; Oyen WJ; Weber WA
J Nucl Med; 2014 May; 55(5):701-4. PubMed ID: 24732155
[TBL] [Abstract][Full Text] [Related]
29. Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats.
Elo P; Li XG; Liljenbäck H; Helin S; Teuho J; Koskensalo K; Saunavaara V; Marjamäki P; Oikonen V; Virta J; Chen Q; Low PS; Knuuti J; Jalkanen S; Airas L; Roivainen A
J Neuroinflammation; 2019 Dec; 16(1):252. PubMed ID: 31796042
[TBL] [Abstract][Full Text] [Related]
30. Folate-targeted chemotherapy.
Leamon CP; Reddy JA
Adv Drug Deliv Rev; 2004 Apr; 56(8):1127-41. PubMed ID: 15094211
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and in vitro evaluation of defined HPMA folate conjugates: influence of aggregation on folate receptor (FR) mediated cellular uptake.
Barz M; Canal F; Koynov K; Zentel R; Vicent MJ
Biomacromolecules; 2010 Sep; 11(9):2274-82. PubMed ID: 20687544
[TBL] [Abstract][Full Text] [Related]
32. Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
Hilgenbrink AR; Low PS
J Pharm Sci; 2005 Oct; 94(10):2135-46. PubMed ID: 16136558
[TBL] [Abstract][Full Text] [Related]
33. Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid.
Péraudeau E; Cronier L; Monvoisin A; Poinot P; Mergault C; Guilhot F; Tranoy-Opalinski I; Renoux B; Papot S; Clarhaut J
J Control Release; 2018 Jan; 269():36-44. PubMed ID: 29129656
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
36. Tumour-selective drug delivery via folate receptor-targeted liposomes.
Pan X; Lee RJ
Expert Opin Drug Deliv; 2004 Nov; 1(1):7-17. PubMed ID: 16296717
[TBL] [Abstract][Full Text] [Related]
37. Reduced
Boss SD; Müller C; Siwowska K; Büchel JI; Schmid RM; Groehn V; Schibli R; Ametamey SM
Bioconjug Chem; 2018 Apr; 29(4):1119-1130. PubMed ID: 29412638
[TBL] [Abstract][Full Text] [Related]
38. Targeting therapeutic and imaging agents to folate receptor positive tumors.
Reddy JA; Allagadda VM; Leamon CP
Curr Pharm Biotechnol; 2005 Apr; 6(2):131-50. PubMed ID: 15853692
[TBL] [Abstract][Full Text] [Related]
39. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
Lu Y; Sega E; Leamon CP; Low PS
Adv Drug Deliv Rev; 2004 Apr; 56(8):1161-76. PubMed ID: 15094213
[TBL] [Abstract][Full Text] [Related]
40. Folate-linked lipid-based nanoparticle for targeted gene delivery.
Hattori Y; Maitani Y
Curr Drug Deliv; 2005 Jul; 2(3):243-52. PubMed ID: 16305426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
